Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 20 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Salvage second hematopoietic cell transplantation in myelomaMichaelis, L.; Saad, A.; Zhong, X.; Le-Rademacher, J.; Freytes, C.; Marks, D.; Lazarus, H.; Bird, J.; Holmberg, L.; Kamble, R.; Kumar, S.; Lill, M.; Meehan, K.; Saber, W.; Schriber, J.; Tay, J.; Vogl, D.; Wirk, B.; Savani, B.; Gale, R.; et al.
2021The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort studyHodgson, C.L.; Higgins, A.M.; Bailey, M.J.; Mather, A.M.; Beach, L.; Bellomo, R.; Bissett, B.; Boden, I.J.; Bradley, S.; Burrell, A.; Cooper, D.J.; Fulcher, B.J.; Haines, K.J.; Hopkins, J.; Jones, A.Y.M.; Lane, S.; Lawrence, D.; van der Lee, L.; Liacos, J.; Linke, N.J.; et al.
2012Death adder envenoming causes neurotoxicity not reversed by antivenom - Australian snakebite project (ASP-16)Johnston, C.; O'Leary, M.; Brown, S.; Currie, B.; Halkidis, L.; Whitaker, R.; Close, B.; Isbister, G.; Nagree, Y.; Ker, F.; Greene, S.; Taylor, M.; Macrokanis, C.; Wilke, G.; Coulson, A.; Barnes, C.; Bonni, R.; Whitake, R.; Halkidis, L.; Isbiste, G.; et al.; de Silva, J.
2015A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinomaPal, S.; Azad, A.; Bhatia, S.; Drabkin, H.; Costello, B.; Sarantopoulos, J.; Kanesvaran, R.; Lauer, R.; Starodub, A.; Hauke, R.; Sweeney, C.; Hahn, N.; Sonpavde, G.; Richey, S.; Breen, T.; Kremmidiotis, G.; Leske, A.; Doolin, E.; Bibby, D.; Simpson, J.; et al.
2015TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsYeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
2008Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trialDavis, S.; Donnan, G.; Parsons, M.; Levi, C.; Butcher, K.; Peeters, A.; Barber, P.; Bladin, C.; De Silva, D.; Byrnes, G.; Chalk, J.; Fink, J.; Kimber, T.; Schultz, D.; Hand, P.; Frayne, J.; Hankey, G.; Muir, K.; Gerraty, R.; Tress, B.; et al.
2011Apixaban versus Warfarin in patients with atrial fibrillationGranger, C.; Alexander, J.; McMurray, J.; Lopes, R.; Hylek, E.; Hanna, M.; Al-Khalidi, H.; Ansell, J.; Avezum, A.; Atar, D.; Bahit, M.; Diaz, R.; Easton, J.; Ezekowitz, J.; Garcia, D.; Geraldes, M.; Gersh, B.; Golitsyn, S.; Goto, S.; Hermosillo, A.; et al.
2015Analysis of KRAS/NRAS mutations in a phase III study of panitumumab with FOLFIRI compared with FOLFIRI zlone as second-line treatment for metastatic colorectal cancerPeeters, M.; Oliner, K.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; André, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; He, P.; Yu, H.; Koukakis, R.; Terwey, J.; et al.
2017Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trialRutten, M.; Van Meurs, H.; Van De Vrie, R.; Gaarenstroom, K.; Naaktgeboren, C.; Van Gorp, T.; Brugge, H.; Hofhuis, W.; Schreuder, H.; Arts, H.; Zusterzeel, P.; Pijnenborg, J.; Van Haaften, M.; Fons, G.; Engelen, M.; Boss, E.; Vos, M.; Gerestein, K.; Schutter, E.; Opmeer, B.; et al.
2019Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study ReportWu, Z.; Luu, C.D.; Hodgson, L.A.B.; Caruso, E.; Brassington, K.H.; Tindill, N.; Aung, K.Z.; Harper, C.A.; Wickremasinghe, S.S.; Sandhu, S.S.; McGuinness, M.B.; Chen, F.K.; Chakravarthy, U.; Arnold, J.J.; Heriot, W.J.; Durkin, S.R.; Wintergerst, M.W.M.; Gorgi Zadeh, S.; Schultz, T.; Finger, R.P.; et al.